These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6742676)

  • 21. [Transdermal scopolamine patches and anisocoria].
    Roquer JM; Vila A; Roure C
    Med Clin (Barc); 1995 May; 104(17):677-8. PubMed ID: 7623499
    [No Abstract]   [Full Text] [Related]  

  • 22. Transient bilateral pupillary dilation from scopolamine discs.
    Patterson JH; Ives TJ; Greganti MA
    Drug Intell Clin Pharm; 1986 Dec; 20(12):986-7. PubMed ID: 3816553
    [No Abstract]   [Full Text] [Related]  

  • 23. Delayed hypersensitivity to scopolamine delivered by a transdermal device.
    Trozak DJ
    J Am Acad Dermatol; 1985 Aug; 13(2 Pt 1):247-51. PubMed ID: 2931457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transdermal scopolamine for motion sickness.
    Med Lett Drugs Ther; 1981 Oct; 23(21):89-90. PubMed ID: 7027000
    [No Abstract]   [Full Text] [Related]  

  • 25. Scopolamine anisocaria.
    Hughes SS; Zaloga GP
    Ann Emerg Med; 1989 Apr; 18(4):423-4. PubMed ID: 2705676
    [No Abstract]   [Full Text] [Related]  

  • 26. Scopolamine bioavailability in combined oral and transdermal delivery.
    Nachum Z; Shahal B; Shupak A; Spitzer O; Gonen A; Beiran I; Lavon H; Eynan M; Dachir S; Levy A
    J Pharmacol Exp Ther; 2001 Jan; 296(1):121-3. PubMed ID: 11123371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventing motion sickness.
    Hodgson T
    Can Med Assoc J; 1982 Jun; 126(12):1374. PubMed ID: 7083089
    [No Abstract]   [Full Text] [Related]  

  • 28. Transdermal scopolamine use for post-rhytidectomy sialocele.
    Lapid O; Kreiger Y; Sagi A
    Aesthetic Plast Surg; 2004; 28(1):24-8. PubMed ID: 15116278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scopolamine: new preparations. Reference treatment for death rattle.
    Prescrire Int; 2001 Aug; 10(54):99-101. PubMed ID: 11718188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No causal relationship between transdermal scopolamine and seizures: methodologic lessons for pharmacoepidemiology.
    Strom BL; Carson JL; Schinnar R; Snyder ES; Shaw M; Waiter SL
    Clin Pharmacol Ther; 1991 Jul; 50(1):107-13. PubMed ID: 1855348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scopolamine for prevention of postoperative nausea in gynecologic laparoscopy, a randomized trial.
    Einarsson JI; Audbergsson BO; Thorsteinsson A
    J Minim Invasive Gynecol; 2008; 15(1):26-31. PubMed ID: 18262140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transdermal scopolamine withdrawal syndrome.
    Feder RE
    Clin Neuropharmacol; 1999; 22(2):120. PubMed ID: 10202610
    [No Abstract]   [Full Text] [Related]  

  • 33. Experimental motion sickness: efficacy of transdermal scopolamine plus ephedrine.
    Graybiel A; Cramer DB; Wood CD
    Aviat Space Environ Med; 1981 Jun; 52(6):337-9. PubMed ID: 7259691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal scopolamine and toxic psychosis.
    Rodysill KJ; Warren JB
    Ann Intern Med; 1983 Apr; 98(4):561. PubMed ID: 6838088
    [No Abstract]   [Full Text] [Related]  

  • 35. A simple test for scopolamine mydriasis.
    Larson MD
    Anesth Analg; 1991 Dec; 73(6):824. PubMed ID: 1796980
    [No Abstract]   [Full Text] [Related]  

  • 36. Psychosis due to transdermally administered scopolamine.
    MacEwan GW; Remick RA; Noone JA
    CMAJ; 1985 Sep; 133(5):431-2. PubMed ID: 4027811
    [No Abstract]   [Full Text] [Related]  

  • 37. Transdermal scopolamine as a cause of transient psychosis in two elderly patients.
    Mego DM; Omori JM; Hanley JF
    South Med J; 1988 Mar; 81(3):394-5. PubMed ID: 3347867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed hypersensitivity to scopolamine in transdermal therapeutic systems.
    van der Willigen AH; Oranje AP; Stolz E; van Joost T
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 1):146-7. PubMed ID: 3346401
    [No Abstract]   [Full Text] [Related]  

  • 39. Toxic psychosis from transdermal scopolamine in a child.
    Sennhauser FH; Schwarz HP
    Lancet; 1986 Nov; 2(8514):1033. PubMed ID: 2877187
    [No Abstract]   [Full Text] [Related]  

  • 40. Results of a randomized double-blind crossover trial of scopolamine versus placebo administered by transdermal patch for the control of cisplatin-induced emesis.
    Longo DL; Wesley M; Howser D; Hubbard SM; Anderson T; Young RC
    Cancer Treat Rep; 1982 Nov; 66(11):1975-6. PubMed ID: 6890407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.